121 related articles for article (PubMed ID: 23240172)
41. Progress in vaccines, progress in health economics.
Annemans L
Vaccine; 2010 Nov; 28 Suppl 6():G1-2. PubMed ID: 21075264
[No Abstract] [Full Text] [Related]
42. Vaccine-preventable severe morbidity and mortality caused by meningococcus and pneumococcus: A population-based study in France.
Lorton F; Chalumeau M; Assathiany R; Martinot A; Bucchia M; Roué JM; Bourgoin P; Chantreuil J; Boussicault G; Gaillot T; Saulnier JP; Caillon J; Levy C; Cohen R; Gras-Le Guen C; Launay E
Paediatr Perinat Epidemiol; 2018 Sep; 32(5):442-447. PubMed ID: 30170336
[TBL] [Abstract][Full Text] [Related]
43. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
Haveman LM; Geelen SP; Sanders EA; Wolfs TF
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904
[TBL] [Abstract][Full Text] [Related]
44. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT
Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758
[TBL] [Abstract][Full Text] [Related]
45. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
Long SS
Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
[No Abstract] [Full Text] [Related]
46. [Universal vaccination against group C meningococci and pneumococci; advice from the Health Council of the Netherlands].
van Furth AM; Vandenbroucke-Grauls CM
Ned Tijdschr Geneeskd; 2002 May; 146(20):932-3. PubMed ID: 12051059
[TBL] [Abstract][Full Text] [Related]
47. [New ideas on the therapeutic effect of a combination of vaccines against pneumococcal, Haemophilus influenzae type b infection, and influenza in patients with chronic obstructive pulmonary disease].
Kostinov MP; Zhestkov AV; Protasov AD; Magarshak OO; Kostinova TA
Ter Arkh; 2015; 87(3):17-22. PubMed ID: 26027235
[TBL] [Abstract][Full Text] [Related]
48. Case-control studies of the effectiveness of vaccines: validity and assessment of potential bias.
Shapiro ED
Pediatr Infect Dis J; 2004 Feb; 23(2):127-31. PubMed ID: 14872178
[TBL] [Abstract][Full Text] [Related]
49. Role of laboratories in population-based surveillance of invasive diseases in Lazio, Italy, 1998-2000.
Faustini A; Fabrizi E; Sangalli M; Bordi E; Cipriani P; Fiscarelli E; Perucci CA
Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):824-6. PubMed ID: 12461595
[No Abstract] [Full Text] [Related]
50. Hospitalization rates and outcome of invasive bacterial vaccine-preventable diseases in Tuscany: a historical cohort study of the 2000-2016 period.
Chiappini E; Inturrisi F; Orlandini E; de Martino M; de Waure C
BMC Infect Dis; 2018 Aug; 18(1):396. PubMed ID: 30103691
[TBL] [Abstract][Full Text] [Related]
51. Meningococcal C vaccines: the Canadian experience.
De Wals P
Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
[TBL] [Abstract][Full Text] [Related]
52. [Significant decline of the number of invasive Haemophilus influenzae infections in the first 4 years after introduction of vaccination against H. influenzae type B in children].
Conyn-van Spaendonck MA; Veldhuijzen IK; Suijkerbuijk AW; Hirasing RA
Ned Tijdschr Geneeskd; 2000 May; 144(22):1069-73. PubMed ID: 10850110
[TBL] [Abstract][Full Text] [Related]
53. Immunogenicity and safety of CRM₁₉₇ conjugated 9-valent pneumococcal and meningococcal C combination vaccine in healthy infants.
Mallet E; Brachet E; Fernsten P; Laudat F; Razmpour A; Gruber WC;
Vaccine; 2011 Aug; 29(34):5812-9. PubMed ID: 21296118
[TBL] [Abstract][Full Text] [Related]
54. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
[TBL] [Abstract][Full Text] [Related]
55. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.
Slack MH; Schapira D; Thwaites RJ; Burrage M; Southern J; Andrews N; Borrow R; Goldblatt D; Miller E
J Infect Dis; 2001 Dec; 184(12):1617-20. PubMed ID: 11740740
[TBL] [Abstract][Full Text] [Related]
56. Challenges in immunisation against bacterial infection in children.
Trück J; Pollard AJ
Early Hum Dev; 2010 Nov; 86(11):695-701. PubMed ID: 20851537
[TBL] [Abstract][Full Text] [Related]
57. Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants.
Ruiz-Palacios GM; Guerrero ML; Hernández-Delgado L; Lavalle-Villalobos A; Casas-Muñoz A; Cervantes-Apolinar Y; Moreira M; Schuerman L
Hum Vaccin; 2011 Nov; 7(11):1137-45. PubMed ID: 22048109
[TBL] [Abstract][Full Text] [Related]
58. Meningococcal disease: a review on available vaccines and vaccines in development.
Bröker M; Fantoni S
Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
[TBL] [Abstract][Full Text] [Related]
59. HHS-CDC news: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--US, 1998-2003.
Ann Pharmacother; 2005 Nov; 39(11):1967-8. PubMed ID: 16219891
[No Abstract] [Full Text] [Related]
60. Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009.
von Gottberg A; Cohen C; Whitelaw A; Chhagan M; Flannery B; Cohen AL; de Gouveia L; Plessis Md; Madhi SA; Klugman KP;
Vaccine; 2012 Jan; 30(3):565-71. PubMed ID: 22119925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
